SRPL
Shree Ram Proteins Limited
Shree Ram Proteins Limited (SRPL) financial statements and selected valuation metrics through 30 June 2026.
shreeramproteins.com(opens the company website in a new tab)Key metrics
Price as of 2026-08-10
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Shree Ram Proteins is a Rajkot, Gujarat-based company that reports a single operating segment but has booked no revenue from operations in FY25 or FY26 and is in default on its loans and statutory dues, with its board now proposing to sell substantially the whole of its undertaking.
What we see
- ✓110% of operating profit came in as cash over the last three years — profits are backed by real cash.
- ✗Interest coverage of -341.9x — earnings barely cover interest payments, which is a warning sign.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Operating expenses (approx.) | 7 Cr | 5 Cr | 3 Cr | 0.25 Cr | 11 Cr | 4 Cr | 4 Cr | 2 Cr | 0.11 Cr | 0.18 Cr | 2 Cr | 0.47 Cr |
| EBITDA | -2 Cr | -5 Cr | -3 Cr | -0.25 Cr | -11 Cr | -4 Cr | -4 Cr | -2 Cr | -0.11 Cr | -0.18 Cr | -2 Cr | -0.47 Cr |
| OPM % | -32.0% | — | — | — | — | — | — | — | — | — | — | — |
| Other income | 0.23 Cr | 0 Cr | 0.01 Cr | 0 Cr | 3 Cr | 0.03 Cr | 0.02 Cr | 0.01 Cr | 0 Cr | 0 Cr | 0.01 Cr | 1 Cr |
| Interest | 0.36 Cr | 0.0068 Cr | 0 Cr | 0 Cr | 3 Cr | 0.02 Cr | 0 Cr | 0 Cr | 0.01 Cr | 0 Cr | 0 Cr | 7 Cr |
| Depreciation | 0.21 Cr | 0.21 Cr | 0.21 Cr | 0.17 Cr | 0.03 Cr | 0.31 Cr | 0.17 Cr | 0.14 Cr | 0.14 Cr | 0.14 Cr | 0.14 Cr | 0.09 Cr |
| Profit before tax | -2 Cr | -5 Cr | -3 Cr | -0.42 Cr | -12 Cr | -5 Cr | -4 Cr | -2 Cr | -5 Cr | -0.32 Cr | -3 Cr | -6 Cr |
| Tax % | 12.0% | 3.8% | 4.8% | -20.1% | 0.0% | 0.0% | 0.5% | 0.3% | 0.1% | 1.6% | -14.5% | -0.0% |
| Net profit | -2 Cr | -5 Cr | -3 Cr | -0.50 Cr | -12 Cr | -5 Cr | -4 Cr | -2 Cr | -5 Cr | -0.32 Cr | -3 Cr | -6 Cr |
| EPS (₹) | ₹-0.09 | ₹-0.21 | ₹-0.15 | ₹-0.02 | ₹-0.54 | ₹-0.22 | ₹-0.20 | ₹0.08 | ₹-0.23 | ₹0.01 | ₹-0.14 | ₹-0.30 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 153 Cr | 288 Cr | 163 Cr | 15 Cr | 0 Cr | 0 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 147 Cr | 275 Cr | 152 Cr | 23 Cr | 19 Cr | 3 Cr | Sign in free for the trailing twelve months |
| EBITDA | 6 Cr | 13 Cr | 11 Cr | -8 Cr | -19 Cr | -3 Cr | Sign in free for the trailing twelve months |
| OPM % | 3.8% | 4.5% | 6.5% | -55.6% | — | — | Sign in free for the trailing twelve months |
| Other income | 0.12 Cr | 0.76 Cr | 0.05 Cr | 0.34 Cr | 3 Cr | 0.03 Cr | Sign in free for the trailing twelve months |
| Interest | 4 Cr | 4 Cr | 4 Cr | 1 Cr | 3 Cr | 0.01 Cr | Sign in free for the trailing twelve months |
| Depreciation | 1 Cr | 0.90 Cr | 0.99 Cr | 0.82 Cr | 0.67 Cr | 0.57 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 1 Cr | 8 Cr | 5 Cr | -10 Cr | -21 Cr | -10 Cr | Sign in free for the trailing twelve months |
| Tax % | 23.7% | 25.5% | 27.2% | 5.2% | -0.3% | -3.7% | Sign in free for the trailing twelve months |
| Net profit | 0.84 Cr | 6 Cr | 4 Cr | -10 Cr | -21 Cr | -10 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹0.39 | ₹2.87 | ₹1.79 | ₹-0.45 | ₹-0.98 | ₹-0.47 | Sign in free for the trailing twelve months |
| Dividend payout % | 0.0% | 0.0% | 0.0% | — | — | — | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 21 Cr | 21 Cr | 21 Cr | 21 Cr | 21 Cr | 21 Cr |
| Reserves | 25 Cr | 31 Cr | 35 Cr | 25 Cr | 4 Cr | -6 Cr |
| Borrowings | 44 Cr | 43 Cr | 37 Cr | 37 Cr | 38 Cr | 37 Cr |
| Other liabilities | 10 Cr | 21 Cr | 13 Cr | 15 Cr | 15 Cr | 17 Cr |
| Total liabilities | 100 Cr | 116 Cr | 106 Cr | 98 Cr | 79 Cr | 69 Cr |
| Fixed assets (net) | 7 Cr | 7 Cr | 7 Cr | 6 Cr | 0 Cr | 4 Cr |
| CWIP | — | — | 0.05 Cr | — | 5 Cr | — |
| Investments | 0.0016 Cr | — | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Inventories | 47 Cr | 63 Cr | 39 Cr | 36 Cr | 17 Cr | 11 Cr |
| Trade receivables | 43 Cr | 8 Cr | 28 Cr | 24 Cr | 24 Cr | 24 Cr |
| Cash & bank | 1.00 Cr | 31 Cr | 0.04 Cr | 0.10 Cr | 0.01 Cr | 0.01 Cr |
| Other assets | 1 Cr | 7 Cr | 32 Cr | 33 Cr | 33 Cr | 30 Cr |
| Total assets | 100 Cr | 116 Cr | 106 Cr | 98 Cr | 79 Cr | 69 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | 0.86 Cr | 36 Cr | -20 Cr | 0.59 Cr | 2 Cr | 0.97 Cr |
| Cash from investing | -0.01 Cr | -0.24 Cr | -1 Cr | 0.90 Cr | 0 Cr | 0.03 Cr |
| Cash from financing | -0.60 Cr | -6 Cr | -10 Cr | -1 Cr | -2 Cr | -1 Cr |
| Net cash flow | 0.24 Cr | 30 Cr | -31 Cr | 0.05 Cr | -0.08 Cr | -0.0001 Cr |
| Free cash flow (OCF − Capex) | 0.84 Cr | 36 Cr | -21 Cr | 0.58 Cr | 2 Cr | 0.97 Cr |
Ratios
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 5.4% | 13.4% | 10.3% | -10.4% | -27.7% | -18.5% |
| ROE % | 1.8% | 11.8% | 6.9% | -20.6% | -82.7% | -65.9% |
| Debtor days | 104 | 10 | 62 | 586 | — | — |
| Inventory days | 222 | 99 | 113 | 779 | — | — |
| Days payable | 43 | 29 | 24 | 211 | — | — |
| Cash conversion cycle | 283 | 79 | 151 | 1154 | — | — |
| OCF / EBITDA % | 14.9% | 282.2% | -192.3% | — | — | — |
| OCF / EBITDA % (3 years) | — | — | 58.1% | 109.9% | — | — |
| Debt / equity | 0.95 | 0.81 | 0.66 | 0.79 | 1.50 | 2.42 |
| Current ratio | 2.22 | 2.06 | 2.35 | 2.22 | 1.84 | 1.75 |
| Net debt / EBITDA | — | — | 3.51 | — | — | — |